Nyhet -

GU-Holding declares A+ Science their best investment yet

1997 marks the start of an international clinical study that some years later stopped early for efficacy. That study was also the start of a Contract Research Organization that investor GU-holding decided to be a part of. The investment came to be GU-holdings best investment yet, an achievement they decided to award November 17, when celebrating their 15th anniversary. Björn Dahlöf received the award on behalf of A+ Science and the founders.

The study was initially meant to be coordinated from the Sahlgrenska University Hospital/Östra. However the project grew in scope and a company, later named A+ Science was formed and the study came to be known as ASCOT, involving close to 20 000 patients at 700 sites in 6 countries. A+ Science managed data management, endpoint handling, core lab, study administration, overall study logistics, some monitoring and filing to FDA.

Read more at GU-Holding (in Swedish).

Ämnen

  • Hälsa, sjukvård, läkemedel

Kontakter

Ulf Skough

Presskontakt CEO +46 8 564 882 30